Results - Announcements
Sai Life Sciences Ltd share price inched up 3.23% to Rs 1596.2 after the company's net profit soared by 34.15% to Rs 98.32 crore, while revenue from operations edged up 18.82% to Rs 658.59 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.82 lakh crore, gaining 5.29%. It has improved by 2.18% over last one week and ticked higher by 2.72% in last one month while the market capitalization of Sai Life Sciences Ltd has marginally improved by 2.34% and 17.23% in the same period respectively.
Profit before tax (PBT) of Sai Life Sciences Ltd stood at Rs 131.28 crore in Q3 FY26, surging by 17.16% year-on-year, and jumping 34.00% quarter-on-quarter. EBITDA came in at Rs 182 crore, expanding by 39.78% YoY and rallying 26.26% sequentially.
Total expenses advancing by 15.06% to Rs 520.33 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 170.07 crore, softening by 4.37% YoY, while employee benefits expense was at Rs 198.06 crore, rising by 10.09% YoY.
For the TTM ended FY26, revenue from operations surged 29.38% to Rs 2192.49 crore, while net profit saw a strong growth of 105.08% to Rs 348.91 crore, compared to previous TTM. EBITDA jumped by 39617% to Rs 582.03 crore, and PBT witnessed a strong rise of 104.74% to Rs 466.19 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 509.13 crore in FY26, as against Rs 314.05 crore in FY25.
Sai Life Sciences Ltd jumped 73.10% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 4.80% during the same period.